Opinion
Article
Survey: How Have the Tariffs & Trade Policy Affected the Pharmaceutical Industry?
Author(s):
Key Takeaways
- Bio/pharmaceutical manufacturers are strained by evolving trade policies and tariffs, affecting profits and operational strategies.
- Tariffs disrupt the flow of finished products and raw materials, complicating compliance and cost forecasting.
Complete this survey to illustrate how new tariffs and trade policy have impacted you and your organization.
Credit: freshidea | stock.adobe.com. Economic tariffs and government taxation or punative tariff trade policy or duties imposed on imports and exports by a government on imported or exported goods as Protectionism.
Bio/pharmaceutical manufacturers are increasingly strained by evolving trade policies and tariff regimes, explained Jason Waite, international trade lead at Alston & Bird, in our recent interview series with him.
Recent data from Enable show more than three-quarters of UK businesses have already lost profit due to tariffs, with 91% expressing concern over the impact of tariffs in the next 12 months and nearly one-third saying they are “extremely concerned.” Companies are being forced to reassess operations, supply chains, and pricing strategies.
“Adding to the confusion, President Trump has also announced wider tariffs against specific countries,” wrote Mike Hollan in Pharmaceutical Executive. “In some deals, such as the one he signed with the European Union, pharmaceuticals are included.”
For those operating in the bio/pharmaceutical sector, tariffs have disrupted not only finished product shipments but also the flow of active pharmaceutical ingredients and raw materials critical for production, explains Waite. Regulatory complexities and inconsistent enforcement further compound these challenges, complicating long-term planning for compliance, cost forecasting, and sourcing.
The heightened sensitivity to trade policy in the sector underscores a broader concern: that global pharmaceutical manufacturing now depends on more than regulatory approval and technical quality; it also hinges on geopolitical stability and predictability in trade relationships.
Share your voice!
Help us get a better picture of how new tariffs and trade policy have impacted you and your organization. Check back in a couple weeks to see where you stand among your peers! All who complete the survey will be entered for a chance to win a $25 Amazon gift card.
NO PURCHASE NECESSARY. Void where prohibited. See Official Rules at https://www.pharmtech.com/view/survey-impacts-of-tariffs-trade-policy-on-the-bio-pharmaceutical-industry for complete details. Odds of winning depend on the number of eligible entries received. Sponsor: MultiMedia Pharma Sciences, LLC.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
